Pricing Strategy

• Payer perceived value (and hence price) of indications varies based on the competitive landscape and perceived added value of your product
• We can support you in determining the payer value of different indications, or assets, to support your indication sequencing and clinical development prioritization

• Understanding what clinical attributes drive payer value (and price) is critical for optimizing your clinical development plan
• We can support you in determining the implications of clinical trial considerations, taking into account the risk/ payer benefit of different trial designs to facilitate clinical trial development that enables both regulatory and HTA approval at a price that represents value to you and healthcare providers

Understanding the value of early-stage assets, or potential in/out licensing opportunities enhances commercial decision making based on evidence based price estimates